Finance

Lists
2367:HKG
Giant Biogene Holding Co Ltd
HK$26.62
+3.50%
(+0.90) 1D
Sep 4, 4:08:01 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2367...
Open
HK$25.72
High
HK$26.62
Low
HK$25.72
Mkt. cap
28.26B
Avg. vol.
0.00
Volume
3.32M
Dividend
2.32%
Quarterly dividend
HK$0.15
Ex-dividend date
Jun 17, 2024
P/E ratio
14.48
52-wk high
HK$65.70
52-wk low
HK$24.20
EPS
HK$1.84
Shares outstanding
1.06B
No. of employees
2K
Open
HK$25.72
High
HK$26.62
Low
HK$25.72
Mkt. cap
28.26B
Avg. vol.
0.00
Volume
3.32M
Dividend
2.32%
Quarterly dividend
HK$0.15
Ex-dividend date
Jun 17, 2024
P/E ratio
14.48
52-wk high
HK$65.70
52-wk low
HK$24.20
EPS
HK$1.84
Shares outstanding
1.06B
No. of employees
2K
About Giant Biogene Holding Co Ltd
CEO-
Employees2.32K
Founded2000
Headquarters-
SectorPersonal care products
Websitexajuzi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.20B
1.20B
1.46B
1.46B
Cost of goods sold
257.42M
257.42M
299.64M
299.64M
Cost of revenue
257.42M
257.42M
299.64M
299.64M
Research and development expenses
23.81M
23.81M
22.76M
22.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
541.58M
541.58M
673.36M
673.36M
Operating expense
565.15M
565.15M
687.61M
687.61M
Total operating expenses
822.57M
822.57M
987.25M
987.25M
Operating income
380.35M
380.35M
471.59M
471.59M
Other non operating income
-1.55M
-1.55M
12.66M
12.66M
EBT including unusual items
453.08M
453.08M
547.48M
547.48M
EBT excluding unusual items
428.11M
428.11M
547.48M
547.48M
Income tax expense
86.97M
86.97M
77.71M
77.71M
Effective tax rate
19.20%
19.20%
14.19%
14.19%
Other operating expenses
-
-
-8.51M
-8.51M
Net income
366.38M
366.38M
469.86M
469.86M
Net profit margin
30.46%
30.46%
32.21%
32.21%
Earnings per share
-
-
-
-
Interest and investment income
52.14M
52.14M
58.40M
58.40M
Interest expense
-89.00K
-89.00K
-87.50K
-87.50K
Net interest expenses
52.05M
52.05M
58.31M
58.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
400.13M
400.13M
490.13M
490.13M
Gain or loss from assets sale
221.50K
221.50K
-
-
AI content may include mistakes. Learn more
Google apps